Cerus Corporation (CERS) - Total Assets
Based on the latest financial reports, Cerus Corporation (CERS) holds total assets worth $221.86 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Cerus Corporation shareholders equity for net asset value and shareholders' equity analysis.
Cerus Corporation - Total Assets Trend (1997–2025)
This chart illustrates how Cerus Corporation's total assets have evolved over time, based on quarterly financial data.
Cerus Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
Cerus Corporation's total assets of $221.86 Million consist of 78.6% current assets and 21.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.0% |
| Accounts Receivable | $30.37 Million | 13.7% |
| Inventory | $56.10 Million | 25.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $1.32 Million | 0.6% |
Asset Composition Trend (1997–2025)
This chart illustrates how Cerus Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Cerus Corporation worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cerus Corporation's current assets represent 78.6% of total assets in 2025, a decrease from 96.0% in 1997.
- Cash Position: Cash and equivalents constituted 9.0% of total assets in 2025, down from 42.5% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1997.
- Asset Diversification: The largest asset category is inventory at 25.3% of total assets.
Cerus Corporation Competitors by Total Assets
Key competitors of Cerus Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055
|
China | CN¥5.70 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €49.14 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Nova EYE Medical Ltd
AU:EYE
|
Australia | AU$23.67 Million |
Cerus Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.73 | 2.39 | 3.31 |
| Quick Ratio | 1.17 | 1.79 | 2.87 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $73.58 Million | $88.41 Million | $126.51 Million |
Cerus Corporation - Advanced Valuation Insights
This section examines the relationship between Cerus Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.57 |
| Latest Market Cap to Assets Ratio | 1.66 |
| Asset Growth Rate (YoY) | 10.4% |
| Total Assets | $221.86 Million |
| Market Capitalization | $368.97 Million USD |
Valuation Analysis
Above Book Valuation: The market values Cerus Corporation's assets above their book value (1.66x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Cerus Corporation's assets grew by 10.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Cerus Corporation (1997–2025)
The table below shows the annual total assets of Cerus Corporation from 1997 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $221.86 Million | +10.42% |
| 2024-12-31 | $200.92 Million | +1.60% |
| 2023-12-31 | $197.75 Million | -9.33% |
| 2022-12-31 | $218.09 Million | -8.17% |
| 2021-12-31 | $237.50 Million | +7.26% |
| 2020-12-31 | $221.41 Million | +33.76% |
| 2019-12-31 | $165.53 Million | +1.27% |
| 2018-12-31 | $163.46 Million | +66.38% |
| 2017-12-31 | $98.24 Million | -5.06% |
| 2016-12-31 | $103.48 Million | -25.81% |
| 2015-12-31 | $139.47 Million | +70.56% |
| 2014-12-31 | $81.77 Million | -1.93% |
| 2013-12-31 | $83.38 Million | +70.45% |
| 2012-12-31 | $48.92 Million | +7.83% |
| 2011-12-31 | $45.37 Million | -5.81% |
| 2010-12-31 | $48.17 Million | +39.65% |
| 2009-12-31 | $34.49 Million | -27.14% |
| 2008-12-31 | $47.34 Million | -39.47% |
| 2007-12-31 | $78.21 Million | -32.47% |
| 2006-12-31 | $115.82 Million | +97.44% |
| 2005-12-31 | $58.66 Million | -42.53% |
| 2004-12-31 | $102.08 Million | -13.83% |
| 2003-12-31 | $118.46 Million | +62.40% |
| 2002-12-31 | $72.95 Million | -43.13% |
| 2001-12-31 | $128.26 Million | +36.21% |
| 2000-12-31 | $94.16 Million | +125.27% |
| 1999-12-31 | $41.80 Million | +100.00% |
| 1998-12-31 | $20.90 Million | -23.44% |
| 1997-12-31 | $27.30 Million | -- |
About Cerus Corporation
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offer… Read more